Outdated regulations and inflexible sponsor processes are hampering clinical trial recruitment, but empowering sites with ...

Federal and state officials have declared war on DEI at North Carolina’s colleges and universities. But what their orders ...

Researchers assessed more than 1,000 results from fruit-fly immunity research published between 1959 and 2011. The majority ...

With the largest number of current studies in North America focusing on improving the patient experience, enhancing ...

The design of recruitment tools for clinical trials impacts rates of enrollment, with higher enrollment seen for shorter letters.

A new study shows that the health of U.S. children has deteriorated over the past 17 years, with kids today more likely to ...

RedHill Biopharma (RDHL) announced the initiation of patient recruitment into the Phase 2 study evaluating the efficacy of opaganib in combination ...

At its Board of Directors meeting on June 19th, the NVDA Board and staff honored Judy Butson for her 33 years of dedicated ...

Pfizer has terminated a Phase II study of its CD47 immune checkpoint inhibitor, maplirpacept, due to low recruitment.

Charles E. Hamner Jr., a highly respected and accomplished scientist, university administrator and pharmaceutical executive who led the North Carolina Biotechnology Center during its formative years, ...

The skills needed in many roles are continually changing—and sources of talent are too.